Complement Receptor Type 1 Suppresses Human B Cell Functions in SLE Patients
Complement receptors (CRs) play an integral role in innate immunity and also function to initiate and shape the adaptive immune response. Our earlier results showed that complement receptor type 1 (CR1, CD35) is a potent inhibitor of the B cell receptor- (BCR-) induced functions of human B lymphocyt...
Main Authors: | Mariann Kremlitzka, Bernadett Mácsik-Valent, Anna Polgár, Emese Kiss, Gyula Poór, Anna Erdei |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/5758192 |
Similar Items
-
Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses
by: Bernadett Mácsik-Valent, et al.
Published: (2019-07-01) -
Revisiting the Coreceptor Function of Complement Receptor Type 2 (CR2, CD21); Coengagement With the B-Cell Receptor Inhibits the Activation, Proliferation, and Antibody Production of Human B Cells
by: Kristóf G. Kovács, et al.
Published: (2021-04-01) -
23 Complement in SLE
by: John Atkinson
Published: (2021-04-01) -
Complement Inhibition in the Treatment of SLE-Associated Thrombotic Thrombocytopenic Purpura
by: Alexis Boneparth MD, et al.
Published: (2015-01-01) -
Dimension transformation formula for conformal maps into the complement of an SLE curve
by: Gwynne, Ewain, et al.
Published: (2021)